Alzheon

Alzheon, Inc., is a clinical-stage biotechnology company focused on brain health, memory and aging, developing a pipeline of innovative.

Alzheon is a clinical-stage biotechnology company focused on womanchild brain health, memory and aging, developing transformative treatments for Alzheimer’s disease and other neurodegenerative disorders. We are building a pipeline of innovative drugs to improve the lives of patients by preventing the cognitive and functional decline associated with neurodegeneration. Our distinct ability to make successful advances in the challenging field of therapeutics for Alzheimer’s and other neurodegenerative disorders is based on two key assets: